Is Bicara Therapeutics Inc. Common Stock (BCAX) a Buy, Sell, or Hold?
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
$28.1 USD
-$0.05 (-0.18%)
- Volume
- 688.9K
- Average Volume
- 690.69K
- Market Capitalization
- $1.54B
- P/E Ratio
- -10.11
- Dividend Yield
- 0.00%
- Price Target
- $37.00
- Year High
- $30.99
- Year Low
- $9.57
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.85
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.00%
Investors Holding
3
change: -151 | last: 154
Increased Positions
1
change: -89 | last: 90
Reduced Positions
0
change: -40 | last: 40
New Positions
0
change: -30 | last: 30
Sold Positions
145
change: 122 | last: 23
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -292.1975 | last: 2.922
Total Invested
57331
BCAX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $16.83 | 54.68M | $920.21M | $96.68M | $1.71M | $825.24M |
| 2024-12-31 | $17.42 | 54.42M | $948.08M | $489.71M | $738K | $459.11M |
| 2023-12-31 | $23.41 | 51.76M | $1.21B | $230.44M | $657K | $981.94M |
| 2022-12-31 | $23.41 | 51.76M | $1.21B | $4.16M | $- | $1.21B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19.89 | 60.72M | $1.21B | $323.46M | $1.44M | $885.64M |
| 2025-12-31 | $16.83 | 55.14M | $928.04M | $96.68M | $1.71M | $833.07M |
| 2025-09-30 | $15.79 | 54.56M | $861.56M | $171.67M | $1.98M | $691.87M |
| 2025-06-30 | $9.29 | 54.54M | $506.67M | $436.61M | $2.24M | $72.3M |
| 2025-03-31 | $13.03 | 54.46M | $709.57M | $462.06M | $591K | $248.09M |
| 2024-12-31 | $17.42 | 54.44M | $948.35M | $489.71M | $738K | $459.37M |
| 2024-09-30 | $25.47 | 54.41M | $1.39B | $520.76M | $445K | $865.5M |
| 2024-06-30 | $23.41 | 54.18M | $1.27B | $203.86M | $517K | $1.07B |
| 2024-03-31 | $23.41 | 54.18M | $1.27B | $203.86M | $517K | $1.07B |
| 2023-12-31 | $23.41 | 53.09M | $1.24B | $230.44M | $657K | $1.01B |
| 2023-09-30 | $23.41 | 54.41M | $1.27B | $- | $- | $1.27B |
| 2023-06-30 | $23.41 | 54.6M | $1.28B | $- | $- | $1.28B |